1-5 of 5
Jonathan Sussman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study

Hira S Mian, MD, Gregory R Pond, PhD PStat, Tanya M. Wildes, MD MSCI, Branavan Sivapathasundaram, MSc, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-133869
Published: 2020
Journal Articles

Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes

Hira S Mian, MD, Gregory R Pond, PhD PStat, Branavan Sivapathasundaram, MSc, Tanya M. Wildes, MD MSCI, Jonathan Sussman, MD FRCPC, MSc, Hsien Seow, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133369
Published: 2020
Journal Articles

Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort

Hira S Mian, MD, C. Tom Kouroukis, MDMSc,FRCPC, Gregory R Pond, PhD PStat, Hsien Seow, PhD, Jonathan Sussman, MD FRCPC, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 268.
https://doi.org/10.1182/blood-2019-121672
Published: 2019
Journal Articles

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Laura N Rodriguez-Romo, MD, Ralph Meyer, MDFRCPC, Joseph L Pater, MD, Jonathan Sussman, MD FRCPC, MSc, Siwei Zhang, MSc, Lui Hongbo, MSc, PhD, Jane N. Winter, MD, Te Vuong, MD, Walter Blahey, MD, Liam Mulroy, MD, Lois E. Shepherd, Marina S Djurfeldt, MSc, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2017) 130 (Supplement 1): 4081.
https://doi.org/10.1182/blood.V130.Suppl_1.4081.4081
Published: 2017
Journal Articles

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC, Stephen Couban, MD, FRCPC, David Macdonald, MD, FRCPC, Vishal Kukreti, MD, C. Tom Kouroukis, MD, MSc, FRCPC, Ralph M. Meyer, MD, Morel Rubinger, MD, Rena Buckstein, MD, Kevin R Imrie, MD, Massimo Federico, MD, Nicola Di Renzo, MD, Kang Howson-Jan, MD, Tara Baetz, MD, Leonard Kaizer, MD FRCPC, Michael Voralia, MD, FRCPC, Harold J. Olney, MD, A. Robert Turner, MD, FRCPC, Jonathan Sussman, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Bingshu E Chen, PhD, Lois Shepherd, MD
Journal: Blood
Blood (2012) 120 (21): 745.
https://doi.org/10.1182/blood.V120.21.745.745
Published: 2012